You are here

China drugmaker in US$764m IPO

[HONG KONG] Luye Pharma Group, a Chinese drugmaker backed by Singapore's sovereign wealth fund, and the company's owners are poised to raise US$764 million from a Hong Kong initial public offering, people with knowledge of the matter said. The company, based in eastern China's Yantai city, plans

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom